After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
NovoCure Ltd is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. The current market capitalization of NovoCure Ltd is $1.27B. A total of 1.59 million shares were traded on the day, compared to an average of 1.59M shares.
In the most recent transaction, Cordova Ashley bought 81,550 shares of NVCR for 12.22 per share on Sep 05 ’25. After the transaction, the Chief Executive Officer now owns 437,569 company shares. In a previous transaction on Jul 29 ’25, Brackmann Christoph bought 20,000 shares at 11.59 per share. NVCR shares that Chief Financial Officer owns now total 141,150.
Among the insiders who sold shares, Stafford Kristin disposed of 999 shares on Jun 03 ’25 at a per-share price of $17.28. This resulted in the Director holding 3,054 shares of NVCR after the transaction. In another insider transaction, LEUNG GABRIEL sold 999 shares at $17.31 per share on Jun 03 ’25. Company shares held by the Director now total 81,229.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NVCR has a high of $34.13 and a low of $10.70.
As of this writing, NVCR has an earnings estimate of -$0.42 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.5. The company reported an EPS of -$0.61 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NVCR’s latest balance sheet shows that the firm has $937.70M in Cash & Short Term Investments as of fiscal 2021. There were $575.21M in debt and $142.60M in liabilities at the time. Its Book Value Per Share was $3.05, while its Total Shareholder’s Equity was $410.49M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVCR is Buy with a score of 4.11.
